Literature DB >> 15479727

FcRH1: an activation coreceptor on human B cells.

Chuen-Miin Leu1, Randall S Davis, Lanier A Gartland, W David Fine, Max D Cooper.   

Abstract

B-cell activation and differentiation is regulated through the coordinated function of a dynamic array of cell surface receptors. At different stages in their differentiation, human B cells may express one or more members of a large family of immunoglobulin Fc receptor homologs (FcRH) with regulatory potential. Among these newly identified transmembrane molecules, FcRH1 is unique in having 2 immunoreceptor tyrosine-based activation motif (ITAM)-like motifs in its intracellular domain. Here we used the Fab fragments of new monoclonal anti-FcRH1 antibodies and mRNA analysis to evaluate FcRH1 expression and function during B-cell differentiation. FcRH1 expression begins in pre-B cells, reaches peak levels on naive B cells, and is down-regulated after B cells are activated to begin to form germinal centers. This FcRH1 down-regulation coincides with dramatic enlargement of the pre-germinal center cells, cell cycle entry, and other overt signs of activation that include CD80 and CD86 up-regulation and immunoglobulin D (IgD) down-regulation. In vitro analysis indicates that ligation of FcRH1 leads to its tyrosine phosphorylation and to modest B-cell activation and proliferation. Concomitant FcRH1 ligation enhances B-cell antigen receptor (BCR)-induced Ca(2+) mobilization and proliferation. FcRH1 thus has the potential to serve as an activating coreceptor on B cells.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15479727     DOI: 10.1182/blood-2004-06-2344

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  32 in total

1.  Involvement of the HCK and FGR src-family kinases in FCRL4-mediated immune regulation.

Authors:  Yanling Liu; Ksenia Bezverbnaya; Tiantian Zhao; Marion J Parsons; Mengyao Shi; Bebhinn Treanor; Götz R A Ehrhardt
Journal:  J Immunol       Date:  2015-05-13       Impact factor: 5.422

2.  Ancient divergence of a complex family of immune-type receptor genes.

Authors:  John P Cannon; Robert N Haire; M Gail Mueller; Ronda T Litman; Donna D Eason; Deborah Tinnemore; Chris T Amemiya; Tatsuya Ota; Gary W Litman
Journal:  Immunogenetics       Date:  2006-04-26       Impact factor: 2.846

3.  Integrative analysis reveals an outcome-associated and targetable pattern of p53 and cell cycle deregulation in diffuse large B cell lymphoma.

Authors:  Stefano Monti; Bjoern Chapuy; Kunihiko Takeyama; Scott J Rodig; Yansheng Hao; Kelly T Yeda; Haig Inguilizian; Craig Mermel; Treeve Currie; Ahmet Dogan; Jeffery L Kutok; Rameen Beroukhim; Donna Neuberg; Thomas M Habermann; Gad Getz; Andrew L Kung; Todd R Golub; Margaret A Shipp
Journal:  Cancer Cell       Date:  2012-09-11       Impact factor: 31.743

4.  FCRL5 exerts binary and compartment-specific influence on innate-like B-cell receptor signaling.

Authors:  Zilu Zhu; Ran Li; Hao Li; Tong Zhou; Randall S Davis
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-18       Impact factor: 11.205

Review 5.  Emerging roles for the FCRL family members in lymphocyte biology and disease.

Authors:  F J Li; W J Won; E J Becker; J L Easlick; E M Tabengwa; R Li; M Shakhmatov; K Honjo; P D Burrows; R S Davis
Journal:  Curr Top Microbiol Immunol       Date:  2014       Impact factor: 4.291

6.  CD21(-/low) marginal zone B cells highly express Fc receptor-like 5 protein and are killed by anti-Fc receptor-like 5 immunotoxins in hepatitis C virus-associated mixed cryoglobulinemia vasculitis.

Authors:  Benjamin Terrier; Satoshi Nagata; Tomoko Ise; Michelle Rosenzwajg; Ira Pastan; David Klatzmann; David Saadoun; Patrice Cacoub
Journal:  Arthritis Rheumatol       Date:  2014-02       Impact factor: 10.995

7.  FCRL6 distinguishes mature cytotoxic lymphocytes and is upregulated in patients with B-cell chronic lymphocytic leukemia.

Authors:  Daniel M Schreeder; Jicun Pan; Fu Jun Li; Eric Vivier; Randall S Davis
Journal:  Eur J Immunol       Date:  2008-11       Impact factor: 5.532

8.  Investigation of the human FCRL1, 2, and 4 gene expressions in patients with rheumatoid arthritis.

Authors:  Ali Khanzadeh; Zahra Habibagahi; Ahmad Hosseini; Zahra Amirghofran
Journal:  Rheumatol Int       Date:  2016-05-18       Impact factor: 2.631

9.  Human Fc receptor-like 5 binds intact IgG via mechanisms distinct from those of Fc receptors.

Authors:  Andrea Franco; Bazarragchaa Damdinsuren; Tomoko Ise; Jessica Dement-Brown; Huifang Li; Satoshi Nagata; Mate Tolnay
Journal:  J Immunol       Date:  2013-04-24       Impact factor: 5.422

10.  FCRL1 on chronic lymphocytic leukemia, hairy cell leukemia, and B-cell non-Hodgkin lymphoma as a target of immunotoxins.

Authors:  Xing Du; Satoshi Nagata; Tomoko Ise; Maryalice Stetler-Stevenson; Ira Pastan
Journal:  Blood       Date:  2007-09-25       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.